WHO international standard for SARS-CoV-2 antibodies to determine markers of protection

WHO international standard for SARS-CoV-2 antibodies to determine markers of protection

Bibliographic Details
Main Authors:	Feng Zhu, Thomas Althaus, Chee Wah Tan, Alizée Costantini, Wan Ni Chia, Nguyen Van Vinh Chau, Le Van Tan, Giada Mattiuzzo, Nicola J Rose, Eric Voiglio, Lin-Fa Wang
Format:	Article
Language:	English
Published:	Elsevier 2022-02-01
Series:	The Lancet Microbe
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666524721003074

Similar Items

WHO international standard for SARS-CoV-2 antibodies to determine markers of protection
by: Zhu, F, et al.
Published: (2021)

WHO International Standard for evaluation of the antibody response to COVID-19 vaccines: call for urgent action by the scientific community
by: Ivana Knezevic, PhD, et al.
Published: (2022-03-01)

Establishment of national standard for anti-SARS-Cov-2 neutralizing antibody in China: The first National Standard calibration traceability to the WHO International Standard
by: Lidong Guan, et al.
Published: (2023-02-01)

Early detection of neutralizing antibodies against SARS-CoV-2 in COVID-19 patients in Thailand.
by: Opass Putcharoen, et al.
Published: (2021-01-01)

Implementing a method for engineering multivalency to substantially enhance binding of clinical trial anti-SARS-CoV-2 antibodies to wildtype spike and variants of concern proteins
by: Adam Leach, et al.
Published: (2021-05-01)

Standardization of SARS-CoV-2 Nucleic Acid Amplification Techniques by Calibration and Quantification to the First WHO International Standard for SARS-CoV-2 RNA
by: Jolanda J. C. Voermans, et al.
Published: (2023-01-01)

Suboptimal porcine endogenous retrovirus infection in non-human primate cells: implication for preclinical xenotransplantation.
by: Giada Mattiuzzo, et al.
Published: (2010-01-01)

Maritime Public Health Cross Border Cooperation: Principality of Monaco and Italian Liguria Health Port Authority Best Practices
by: Antonello Campagna, et al.
Published: (2022-12-01)

Nanobody-Based Blocking of Binding ELISA for the Detection of Anti-NS1 Zika-Virus-Specific Antibodies in Convalescent Patients
by: Triana Delfin-Riela, et al.
Published: (2023-01-01)

Use of a point-of-care test to rapidly assess levels of SARS-CoV-2 nasal neutralising antibodies in vaccinees and breakthrough infected individuals
by: Chee Wah Tan, et al.
Published: (2023-11-01)

Absence of SARS-CoV-2 antibodies in pre-pandemic plasma from children and adults in Vietnam
by: Nguyen Van Vinh Chau, et al.
Published: (2021-10-01)

Differential resistance to cell entry by porcine endogenous retrovirus subgroup A in rodent species
by: Takeuchi Yasuhiro, et al.
Published: (2007-12-01)

More Than Just Gene Therapy Vectors: Lentiviral Vector Pseudotypes for Serological Investigation
by: Kamilla Toon, et al.
Published: (2021-01-01)

The Role of Reference Materials in the Research and Development of Diagnostic Tools and Treatments for Haemorrhagic Fever Viruses
by: Giada Mattiuzzo, et al.
Published: (2019-08-01)

Anti-retroviral innate immune responses in multiple lymphoid tissues elicited by protective live attenuated SIV vaccination
by: Towers Greg, et al.
Published: (2011-10-01)

First clinical study of a new virus-inhibiting surgical glove
by: JL Caillot, et al.
Published: (2008-01-01)

On WHO's standardisation of traditional Chinese medicine terms
by: Tan, Winnie Chee Ying
Published: (2022)

Lack of cross-neutralization by SARS patient sera towards SARS-CoV-2
by: Danielle E. Anderson, et al.
Published: (2020-01-01)

Cross-Neutralisation of Novel Bombali Virus by Ebola Virus Antibodies and Convalescent Plasma Using an Optimised Pseudotype-Based Neutralisation Assay
by: Emma M. Bentley, et al.
Published: (2021-08-01)

Availability and use of Standards in vaccine development
by: Michael Selorm Avumegah, et al.
Published: (2023-06-01)

Mucosal SARS-CoV-2 vaccination of rodents elicits superior systemic T central memory function and cross-neutralising antibodies against variants of concernResearch in context
by: Aled O’Neill, et al.
Published: (2024-01-01)

Overview of Neutralization Assays and International Standard for Detecting SARS-CoV-2 Neutralizing Antibody
by: Kuan-Ting Liu, et al.
Published: (2022-07-01)

GoogleTM android applications with advanced encryption standard (AES)
by: Tan, Chee Yong.
Published: (2011)

Endogenous antibody response to SARS-CoV-2 in patients who received monoclonal antibodies against COVID-19: A systematic review
by: Andrea Lombardi, et al.
Published: (2022-12-01)

Selection of a SARS-CoV-2 antibody quantification method and development of an antibody reference standard for ELISA to test immunoglobulin preparations
by: T. I. Smolyanova, et al.
Published: (2022-12-01)

Preexisting immunity restricts mucosal antibody recognition of SARS-CoV-2 and Fc profiles during breakthrough infections
by: Kevin J. Selva, et al.
Published: (2023-09-01)

Immunogenicity of COVID-19 vaccines and levels of SARS-CoV-2 neutralising antibody in the Bruneian population: Protocol for a national longitudinal study
by: Yan Wang, et al.
Published: (2022-12-01)

Early induction of functional SARS-CoV-2-specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients
by: Anthony T. Tan, et al.
Published: (2021-02-01)

Advanced routing techniques for wireless ad hoc networks
by: Tan, Chee Wah
Published: (2009)

Reconfiguration algorithms for VP based ATM networks
by: Tan, Chee Wah.
Published: (2008)

SARS-CoV-2 spike S2-specific neutralizing antibodies
by: Chia-Jung Li, et al.
Published: (2023-12-01)

Dynamics of Neutralizing Antibody and T-Cell Responses to SARS-CoV-2 and Variants of Concern after Primary Immunization with CoronaVac and Booster with BNT162b2 or ChAdOx1 in Health Care Workers
by: Watsamon Jantarabenjakul, et al.
Published: (2022-04-01)

Absence of SARS-CoV-2 antibodies in pre-pandemic plasma from children and adults in Vietnam
by: Chau, NVV, et al.
Published: (2021)

T cell hybrid immunity against SARS-CoV-2 in children: a longitudinal study
by: Qui, Martin, et al.
Published: (2024)

A super-potent tetramerized ACE2 protein displays enhanced neutralization of SARS-CoV-2 virus infection
by: Ami Miller, et al.
Published: (2021-05-01)

Evaluation of specific IgG antibody in subjects who had been previously infected with SARS-CoV-2
by: Soodabeh Rostami, et al.
Published: (2023-01-01)

Dynamics of antibodies to SARS‐CoV‐2 in convalescent plasma donors
by: Maurice Steenhuis, et al.
Published: (2021-01-01)

Monoclonal Antibodies as SARS-CoV-2 Serology Standards: Experimental Validation and Broader Implications for Correlates of Protection
by: Lili Wang, et al.
Published: (2023-10-01)

CGRP monoclonal antibodies in migraine: an efficacy and tolerability comparison with standard prophylactic drugs
by: Fenne Vandervorst, et al.
Published: (2021-10-01)

Long-Term Humoral Immune Response in Persons with Asymptomatic or Mild SARS-CoV-2 Infection, Vietnam
by: Huynh Kim Mai, et al.
Published: (2021-02-01)